Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 21Breast Neoplasms 18Hematologic Neoplasms 17Colorectal Neoplasms 12Prostatic Neoplasms 11Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Pancreatic Neoplasms 9Hematopoietic and Lymphatic System Neoplasm 9Anatomic Stage I Breast Cancer AJCC v8 9Urinary Bladder Neoplasms 6Ovarian Neoplasms 6Neoplasm Metastasis 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Multiple Myeloma 5Melanoma 5Leukemia, Myeloid, Acute 5Head and Neck Carcinoma 5Breast Carcinoma In Situ 5Triple Negative Breast Neoplasms 4Stomach Neoplasms 4Hematopoietic and Lymphoid System Neoplasm 4Carcinoma, Renal Cell 4Rectal Neoplasms 3Myelodysplastic Syndromes 3Mouth Neoplasms 3Malignant Solid Neoplasm 3Lymphoma 3Head and Neck Neoplasms 3

Interventions

Etoposide 18Cisplatin 16Ifosfamide 14Carboplatin 14Filgrastim 12Bleomycin 12Peripheral Blood Stem Cell Transplantation 9Paclitaxel 9Radiotherapy 6etoposide phosphate 5Thiotepa 5Granulocyte Colony-Stimulating Factor 5Cyclophosphamide 4pegfilgrastim 3Mesna 3Magnetic Resonance Spectroscopy 3liposomal amphotericin B 2ixabepilone 2Vinblastine 2Therapeutics 2Temozolomide 2Specimen Handling 2Psychiatric Rehabilitation 2Oxaliplatin 2Neoadjuvant Therapy 2Immunohistochemistry 2Chemotherapy, Adjuvant 2Amifostine 2sodium thiosulfate 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Teratoma × Practice Guidelines as Topic × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡